Drug Trial Radar · NCT03518086
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Last checked: Nov 20, 2026Latest source record: May 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,281
Actual
Start
Jun 18, 2018
Primary completion
Jan 21, 2021
Study completion May 15, 2024
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- May 8, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.
Conditions
- Ulcerative Colitis
Interventions
MirikizumabDrug
Administered IV
PlaceboDrug
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Clinical Remission at Week 12Time frame: Week 12
Locations
502 sites in 35 countries. Site status is shown where the registry gives one.
Digestive Health Specialists of the Southeast
Dothan, Alabama
Dcr-Pi, Pc
Litchfield Park, Arizona
Maricopa Integrated Health System
Phoenix, Arizona
Physicians Research Group
Tempe, Arizona
Yuma Gastro LLC
Yuma, Arizona
Valley Gastroenterology
Arcadia, California
Care Access Research
Berkeley, California
Citrus Valley Health Partners
Covina, California
Valley View Internal Medicine
Garden Grove, California
Om Research, LLC
Lancaster, California
Catalina Research Institute, LLC
Montclair, California
California Medical Research Associates
Northridge, California
Gastroenterology Associates
Pasadena, California
Clinical Applications Laboratories, Inc.
San Diego, California
UCSF Medical Center at Mission Bay
San Francisco, California
University of Colorado
Aurora, Colorado
Delta Waves Sleep Disorders and Research Center
Colorado Springs, Colorado
Gastroenterology Consultants of Clearwater
Clearwater, Florida
West Central Gastroenterology d/b/a Gastro Florida
Clearwater, Florida
Clinical Research of West Florida, Inc. (Clearwater)
Clearwater, Florida
Pioneer Clinical Research
Coral Springs, Florida
Direct Helpers Medical Center
Hialeah, Florida
The Center for Gastrointestinal Disorders
Hollywood, Florida
Nature Coast Clinical Research, LLC
Inverness, Florida
SIH Research, LLC
Kissimmee, Florida
Columbus Clinical Services, LLC
Miami, Florida
Research Associates of South Florida, LLC
Miami, Florida
IMIC, Inc.
Miami, Florida
Inpatient Research Clinic, LLC
Miami Lakes, Florida
Life Medical Center & Research, Inc
Miami Lakes, Florida
Wellness Clinical Research
Miami Lakes, Florida
Pharma Research International, Inc.
Naples, Florida
Center for Interventional Endoscopy
Orlando, Florida
Clintheory Healthcare
Orlando, Florida
Gastroenterology Associates of Pensacola, PA
Pensacola, Florida
Florida Digestive Specialist
St. Petersburg, Florida
Florida Medical Clinic LLC
Zephyrhills, Florida
Digestive Healthcare of Georgia
Atlanta, Georgia
Gastrointestinal Diseases Research
Columbus, Georgia
Atlanta Gastroenterology Specialists, PC
Suwanee, Georgia
Showing 40 of 502 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.